<VariationArchive VariationID="10419" VariationName="G6PD Amsterdam" VariationType="Deletion" Accession="VCV000010419" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-03-30" DateCreated="2018-02-26" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25458" VariationID="10419">
      <GeneList>
        <Gene Symbol="G6PD" FullName="glucose-6-phosphate dehydrogenase" GeneID="2539" HGNC_ID="HGNC:4057" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154531390" stop="154547569" display_start="154531390" display_stop="154547569" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153759605" stop="153775786" display_start="153759605" display_stop="153775786" Strand="-" />
          </Location>
          <OMIM>305900</OMIM>
        </Gene>
      </GeneList>
      <Name>G6PD Amsterdam</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>G6PD, 3-BP DEL, 180TCT</Name>
      </OtherNameList>
      <ProteinChange>L61del</ProteinChange>
      <ProteinChange>L91del</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042351.1" sequenceAccession="NM_001042351" sequenceVersion="1" change="c.180_182delTCT">
            <Expression>NM_001042351.1:c.180_182delTCT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153764239_153764241del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153764239_153764241del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154536024_154536026del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154536024_154536026del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009015.2" sequenceAccession="NG_009015" sequenceVersion="2" change="g.16549_16551del">
            <Expression>NG_009015.2:g.16549_16551del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000402.4" sequenceAccession="NM_000402" sequenceVersion="4" change="c.270_272del">
            <Expression>NM_000402.4:c.270_272del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000393.4" sequenceAccession="NP_000393" sequenceVersion="4" change="p.Leu91del">
            <Expression>NP_000393.4:p.Leu91del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042351.3" sequenceAccession="NM_001042351" sequenceVersion="3" change="c.180_182del">
            <Expression>NM_001042351.3:c.180_182del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035810.1" sequenceAccession="NP_001035810" sequenceVersion="1" change="p.Leu61del">
            <Expression>NP_001035810.1:p.Leu61del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360016.2" sequenceAccession="NM_001360016" sequenceVersion="2" change="c.180_182del" MANESelect="true">
            <Expression>NM_001360016.2:c.180_182del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001346945.1" sequenceAccession="NP_001346945" sequenceVersion="1" change="p.Leu61del">
            <Expression>NP_001346945.1:p.Leu61del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="305900.0056" DB="OMIM" />
        <XRef Type="rs" ID="2070404412" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff added the HGVS expression for this allele based on the trace in Figure 1 of the paper by van Bruggen et al., 2002 (PubMed 12130518).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="G6PD Amsterdam AND Anemia, nonspherocytic hemolytic, due to G6PD deficiency" Accession="RCV000066279" Version="14">
        <ClassifiedConditionList TraitSetID="2927">
          <ClassifiedCondition DB="MedGen" ID="C2720289">Anemia, nonspherocytic hemolytic, due to G6PD deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-08-12" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-12" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-02-26" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12130518</ID>
        </Citation>
        <DescriptionHistory Dated="2020-05-19">
          <Description>Pathogenic, other</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="2927" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10795" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Class I glucose-6-phosphate dehydrogenase deficiency</ElementValue>
                <XRef ID="466026" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Favism, susceptibility to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anemia, nonspherocytic hemolytic, due to G6PD deficiency</ElementValue>
                <XRef ID="MONDO:0010480" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemolytic anemia due to G6PD deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6520" />
                <XRef ID="6520" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24787449</ID>
                <ID Source="pmc">4111801</ID>
              </Citation>
              <XRef ID="466026" DB="Orphanet" />
              <XRef ID="C2720289" DB="MedGen" />
              <XRef ID="MONDO:0010480" DB="MONDO" />
              <XRef Type="MIM" ID="300908" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="160030" SubmissionDate="2017-05-24" DateLastUpdated="2018-03-25" DateCreated="2013-10-31">
        <ClinVarSubmissionID localKey="305900.0056_ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY" title="G6PD, 3-BP DEL, 180TCT_ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY" />
        <ClinVarAccession Accession="SCV000105932" DateUpdated="2018-03-25" DateCreated="2013-10-31" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000031391" DateChanged="2020-05-14" Version="5">
            <Comment Type="MergeComment">SCV000031391 was merged into SCV000105932 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2002-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a study of blood cells of 4 male patients from 2 unrelated families with nonspherocytic anemia (300908) and recurrent bacterial infections, van Bruggen et al. (2002) discovered that the activity of G6PD in red blood cells and in granulocytes was below detection level. Moreover, their granulocytes displayed a decreased respiratory burst upon activation. Sequencing of genomic DNA revealed a novel 3-bp (TCT) deletion in the G6PD gene, predicting the deletion of a leucine at position 61. The mutant G6PD protein was undetectable by Western blotting in red blood cells and granulocytes of these patients. In phytohemagglutinin-stimulated lymphocytes, the G6PD protein was present, but the amount of the protein was greatly diminished in the patients' cells. Purified mutant protein from an E. coli expression system showed decreased heat stability and decreased specific activity. Furthermore, van Bruggen et al. (2002) demonstrated that mRNA of the mutant G6PD was unstable, which may contribute to the severe G6PD deficiency observed in these patients. They proposed the name 'G6PD Amsterdam' for the new variant.</Attribute>
              <Citation>
                <ID Source="PubMed">12130518</ID>
              </Citation>
              <XRef DB="OMIM" ID="300908" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">One family reported by van Bruggen et al. (2002) was Caucasian, the second was Hindustani. The Caucasian patient had an unremarkable medical history until he was admitted to the hospital at age 15 years with recurrent episodes of fever, jaundice, gastroenteritis, and coughing. He was found to have invasive disseminated aspergillosis (see 614079) in the lungs, brain, and soft tissues of the leg. Aspergillosis was successfully treated. Thereafter, hemoglobin level was normal but reticulocytosis was persistent. One of his brothers also had G6PD deficiency and presented with prolonged neonatal jaundice and episodes of acute hemolysis but had no known disposition to infections.</Attribute>
              <Citation>
                <ID Source="PubMed">12130518</ID>
              </Citation>
              <XRef DB="OMIM" ID="614079" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The Hindustani proband reported by van Bruggen et al. (2002) was healthy until the age of 3.5 years, when he was admitted to the hospital with pneumonia caused by Chromobacterium violaceum, an uncommon human pathogen that can cause serious infections in patients with neutrophil dysfunction. He was anemic. He responded well to chemotherapy, although the anemia persisted. With relapse he developed osteomyelitis but again responded to therapy.</Attribute>
              <Citation>
                <ID Source="PubMed">12130518</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="G6PD" />
          </GeneList>
          <Name>G6PD, 3-BP DEL, 180TCT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 180TCT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="305900.0056" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5079939" SubmissionDate="2022-11-03" DateLastUpdated="2022-11-13" DateCreated="2022-11-13">
        <ClinVarSubmissionID localKey="NM_001042351.1:c.180_182delTCT|OMIM:300908" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002599320" DateUpdated="2022-11-13" DateCreated="2022-11-13" Type="SCV" Version="1" SubmitterName="Dunham Lab, University of Washington" OrgID="508797" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12130518</ID>
          </Citation>
          <Comment>Variant found in hemizygotes in two unrelated families; all have deficiency and one in each family has CNSHA (PP4, PS4_M). On one family, three brothers and heterozygous mother all have deficiency (PP1). Activity in red blood cells is below detection threshold, and purified protein has decreased specific activity (45%) and stability (50%); mRNA stability is also decreased (PS3). Leads to deletion of one amino acid (PM4). Not found in gnomAD (PM2). Post_P 0.999 (odds of pathogenicity 6568, Prior_P 0.1).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Bayesian ACMG Guidelines, 2018</Attribute>
          <Citation>
            <ID Source="PubMed">29300386</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="G6PD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>G6PD Amsterdam</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="2070404412" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001042351.1:c.180_182delTCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300908" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>G6PD_Dunham2022</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3108463" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4984252|MedGen:C2720289" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582831" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12130518</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12130518</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects G6PD protein function (PMID: 12130518). This variant has been observed in individual(s) with glucose-6-phosphate dehydrogenase (G6PD) deficiency (PMID: 12130518). It has also been observed to segregate with disease in related individuals. This variant is also known as G6PD Amsterdam in the literature. ClinVar contains an entry for this variant (Variation ID: 10419). This variant is not present in population databases (ExAC no frequency). This variant, c.180_182del, results in the deletion of 1 amino acid(s) of the G6PD protein (p.Leu61del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="G6PD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153764237_153764239del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2720289" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3108463" TraitType="Disease" MappingType="XRef" MappingValue="C2720289" MappingRef="MedGen">
        <MedGen CUI="C2720289" Name="Anemia, nonspherocytic hemolytic, due to G6PD deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5079939" TraitType="Disease" MappingType="XRef" MappingValue="300908" MappingRef="OMIM">
        <MedGen CUI="C2720289" Name="Anemia, nonspherocytic hemolytic, due to G6PD deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="160030" TraitType="Disease" MappingType="Name" MappingValue="ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY" MappingRef="Alternate">
        <MedGen CUI="C2720289" Name="Anemia, nonspherocytic hemolytic, due to G6PD deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

